Yes, prednisone can cause hip pain, and it’s a side effect worth taking seriously. The most concerning cause is a condition called osteonecrosis (also known as avascular necrosis), where bone tissue in the hip dies because its blood supply gets cut off. About 6.7% of patients taking high cumulative doses of prednisone develop this condition. Prednisone can also weaken the muscles around the hip, creating a second, less severe source of discomfort in the same area.
How Prednisone Damages Hip Bone
The hip joint is uniquely vulnerable to prednisone because the top of the thigh bone (the femoral head) depends on a limited network of blood vessels for oxygen. Prednisone disrupts blood flow to this area through several overlapping pathways. It alters how your body processes fat, causing fat cells to accumulate inside the bone marrow. These enlarged fat deposits physically compress the tiny blood vessels inside the bone, choking off circulation. At the same time, prednisone reduces production of the growth factors your body needs to build new blood vessels, further starving the bone of oxygen.
Prednisone also damages the cells lining blood vessels in the femoral head, promotes a hypercoagulable state that makes blood more likely to clot, and causes the small arteries inside the bone to constrict. The result is a slow suffocation of bone cells. As lipids accumulate inside the bone cells themselves, they swell, their membranes break down, and the cells die. Once enough bone tissue dies, the structural integrity of the femoral head weakens, and it can eventually collapse under your body weight.
What the Pain Feels Like
Osteonecrosis often produces no symptoms in its earliest stages, which makes it easy to miss. As the condition progresses, pain typically appears in the groin, though some people feel it in the buttock instead. The pain usually starts when you put weight on the affected hip, such as when standing or walking, and it may feel mild enough to dismiss at first.
Over time, the pain worsens and can eventually persist even at rest. The hip joint gradually stiffens and loses range of motion, and osteoarthritis can develop in the damaged joint. If the weakened bone surface actually collapses, pain intensifies abruptly. Both hips are frequently affected, not just one.
Dose and Duration That Raise Risk
Not everyone on prednisone faces the same level of risk. The research points to some rough thresholds. A cumulative dose of about 1,000 mg of prednisone taken within a short period is enough to place patients at increased risk. Taking more than 5,000 mg in the first three months of treatment appears to be a critical cutoff. In one analysis, a cumulative dose of 9,000 mg given over a single month carried a 22% incidence of osteonecrosis.
Daily dose matters too. Patients who developed osteonecrosis averaged a peak daily dose of about 44 mg, compared to 28 mg for those who didn’t. Taking more than 40 mg per day during the first month of treatment nearly doubled the likelihood. Each 10 mg per day increase in oral steroids during the first six months raised the risk by about 4.6%. Patients on more than 60 mg per day for longer than two months faced a 1.2-fold increase in risk for every additional two months of exposure at that level.
Cutting cumulative exposure makes a real difference. One study found that reducing the total steroid dose from 12 grams to 6.5 grams cut the incidence of femoral head osteonecrosis by more than half. For patients on high cumulative doses above 10 grams, the odds of developing osteonecrosis were 2.4 times higher than for those on lower regimens.
Muscle Weakness Around the Hip
Prednisone can also cause a separate problem called steroid-induced myopathy, a gradual weakening of muscles that hits the hip girdle earlier and harder than other muscle groups. Unlike osteonecrosis, this condition involves minimal or no pain itself, but the weakness can change how you move, create instability, and lead to aching or discomfort around the hip from compensatory strain. Onset is insidious, developing over weeks to months after starting prednisone, and it comes with visible muscle wasting over time. The weakness affects both sides symmetrically.
Prednisone Also Weakens Bone Density
Beyond osteonecrosis, prednisone accelerates bone loss throughout the skeleton. High-dose users face roughly a 130% increase in hip fracture risk compared to people not taking steroids. This happens because prednisone increases the death rate of the cells that build new bone while also impairing calcium absorption. The combination of weakened bone density and potential osteonecrosis makes the hip particularly vulnerable during long-term steroid therapy. Bone density monitoring with a DXA scan is typically recommended about one year after starting glucocorticoid treatment, and medications that slow bone loss or stimulate new bone growth can help offset the damage.
Why Early Detection Matters
Standard X-rays are poor at catching osteonecrosis in its early stages. They can look completely normal while significant bone damage is already underway, and atypical findings appear in only about 18% of steroid-treated patients on X-ray. MRI is the gold standard, with a sensitivity above 99% for detecting early bone marrow changes like swelling and hardening before the bone collapses. If you’re on prednisone and develop groin or hip pain, an MRI is far more reliable than an X-ray for ruling osteonecrosis in or out.
Early detection changes outcomes significantly. When osteonecrosis is caught before the bone surface collapses, a surgical procedure called core decompression (drilling into the bone to relieve pressure and restore blood flow) produces satisfactory results in about 71% of cases. Without intervention, only about 35% of precollapse cases have good outcomes. Once the femoral head collapses, hip replacement becomes the primary option. The difference between catching this condition early and catching it late can be the difference between keeping your natural hip and needing a prosthetic one.
Reducing Your Risk
The most effective way to lower your risk is to use the lowest effective dose for the shortest possible time. If your medical situation requires prolonged steroid therapy, the cumulative dose is the single most important variable to track. Staying below 5,000 mg in the first three months and keeping daily doses under 40 mg when possible are associated with meaningfully lower rates of osteonecrosis. For bone density protection, calcium and vitamin D supplementation are standard, and prescription medications that either slow bone breakdown or stimulate new bone formation have proven effective in clinical trials for steroid-induced bone loss.
If you’re currently taking prednisone and experiencing new hip or groin pain, particularly pain that worsens with weight-bearing, that’s a symptom that warrants prompt evaluation with imaging rather than a wait-and-see approach.